chr3-61748964-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_002841.4(PTPRG):​c.172C>T​(p.Pro58Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 33)

Consequence

PTPRG
NM_002841.4 missense

Scores

3
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.00
Variant links:
Genes affected
PTPRG (HGNC:9671): (protein tyrosine phosphatase receptor type G) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and two tandem intracytoplasmic catalytic domains, and thus represents a receptor-type PTP. The extracellular region of this PTP contains a carbonic anhydrase-like (CAH) domain, which is also found in the extracellular region of PTPRBETA/ZETA. This gene is located in a chromosomal region that is frequently deleted in renal cell carcinoma and lung carcinoma, thus is thought to be a candidate tumor suppressor gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22630227).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PTPRGNM_002841.4 linkuse as main transcriptc.172C>T p.Pro58Ser missense_variant 2/30 ENST00000474889.6 NP_002832.3 P23470-1Q49A02

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PTPRGENST00000474889.6 linkuse as main transcriptc.172C>T p.Pro58Ser missense_variant 2/301 NM_002841.4 ENSP00000418112.1 P23470-1
PTPRGENST00000295874.14 linkuse as main transcriptc.172C>T p.Pro58Ser missense_variant 2/291 ENSP00000295874.10 P23470-2
PTPRGENST00000495879.1 linkuse as main transcriptn.891C>T non_coding_transcript_exon_variant 2/31
PTPRGENST00000475527.1 linkuse as main transcriptn.609C>T non_coding_transcript_exon_variant 2/25

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 13, 2024The c.172C>T (p.P58S) alteration is located in exon 2 (coding exon 2) of the PTPRG gene. This alteration results from a C to T substitution at nucleotide position 172, causing the proline (P) at amino acid position 58 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.16
T
BayesDel_noAF
Benign
-0.47
CADD
Benign
18
DANN
Uncertain
1.0
DEOGEN2
Benign
0.15
.;T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.090
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.83
T;T
M_CAP
Benign
0.0075
T
MetaRNN
Benign
0.23
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.79
N;N
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.074
Sift
Benign
0.047
D;D
Sift4G
Benign
0.15
T;T
Polyphen
0.0
B;B
Vest4
0.34
MutPred
0.40
Gain of catalytic residue at P58 (P = 0.0231);Gain of catalytic residue at P58 (P = 0.0231);
MVP
0.42
MPC
0.19
ClinPred
0.75
D
GERP RS
5.1
Varity_R
0.24
gMVP
0.58

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr3-61734638; API